Research on chinese medical treatment of refractory idiopathic thrombocytopenic purpura
Yuhong Zhou
Abstract
Yuhong Zhou
Abstract
Refractory idiopathic thrombocytopenic purpura resists to glucocorticoids and splenectomy,resulting in difficulty in clinical treatment.Though choices are various,clinical effect is not ideal.Application of Rituximab and TPO,Romiplostin,Eltrombopag,IL-11 impoves the result.Chinese medical treatment which based onHuo,Xu and Yu can reach better effect through reducing toxicity,increasing effect,stabilizing patient condition,decreasing relapse.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Refractory idiopathic thrombocytopenic purpura resists to glucocorticoids and splenectomy,resulting in difficulty in clinical treatment.Though choices are various,clinical effect is not ideal.Application of Rituximab and TPO,Romiplostin,Eltrombopag,IL-11 impoves the result.Chinese medical treatment which based onHuo,Xu and Yu can reach better effect through reducing toxicity,increasing effect,stabilizing patient condition,decreasing relapse.
Key concepts: Eltrombopag, Thrombocytopenic purpura, Refractory (planetary science), Rituximab, Medicine, Splenectomy, Medical treatment, Gastroenterology